In the News
The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.
Published: May 22, 2018
Author: Andrea S. Blevins Primeau, PhD, MBA
There is no established standard treatment protocol for pediatric chronic myeloid leukemia (CML) and many questions remain regarding long-term outcomes with tyrosine kinase inhibitor (TKI) therapy.
Published: May 21, 2018
A major new analysis reveals for the first time the likely cause of most cases of childhood leukemia, following more than a century of controversy about its origins. Professor Mel Greaves from The Institute ... More >>.
Published: May 14, 2018
Author: James Nam, PharmD
Interim positron-emission tomography (PET) may predict survival, but intensifying treatment based on PET may not improve therapeutic outcomes among patients with aggressive non-Hodgkin lymphoma (NHL), accord ... More >>.
Published: May 10, 2018
Author: James Nam, PharmD
Improvements in the US healthcare system has led to increases of survival among patients with advanced Hodgkin Lymphoma over 3 decades, according to a study in The Oncologist.
Altho ... More >>.
Published: May 07, 2018
The Leukemia & Lymphoma Society (LLS), the largest nonprofit dedicated to fighting blood cancers, today unveiled a new brand platform showcasing its work in the fight to cure cancers. "Beating Cancer is ... More >>.
Published: April 30, 2018
Penn Medicine researchers may have found the reason why some patients with advanced chronic lymphocytic leukemia (CLL) don't respond to chimeric antigen receptor (CAR) T cell therapy, and the answer is tied ... More >>.
Published: April 19, 2018
Author: Bryant Furlow
Chronic lymphocytic leukemia (CLL), a cancer of the immune system that impairs immune competence, can leave patients vulnerable to infection. Hypogammaglobulinemia and associated respiratory bacterial infect ... More >>.
Published: April 17, 2018
Chronic lymphocytic leukemia (CLL) is a hematological malignancy that originates in the blood-forming cells of the bone marrow and spreads to other organs through the bloodstream. When infiltrating tissues, ... More >>.
Published: April 13, 2018
Author: Leah Lawrence
Combining tow drugs, both of which are active as monotherapies in mantle cell lymphoma (MCL), yielded an overall response rate of 71% in a small study recently published in The New England Journ ... More >>.
Published: March 31, 2018
Author: Andrea Greif
The U.S. Food & Drug Administration today announced the first change in 40 years in the standard way that patients newly diagnosed with advanced Hodgkin lymphoma (HL) should be treated.
Today's F ... More >>.